ASG Technologies Acquires Mowbly’s Process Mobility Platform
7.3.2018 14:00:00 EET | Business Wire | Press release
ASG Technologies , a trusted provider of proven solutions for information access, management and control for the world’s top enterprises, today announced that it has acquired Mowbly , an innovative business process mobility platform company. The acquisition extends ASG’s enterprise information management capabilities with the introduction of Business Process Management (BPM) capabilities and enables businesses to construct applications and processes from the perspective of a low-code agile platform with a mobile-first approach.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180307005343/en/
ASG Technologies Acquires Mowbly's Process Mobility Platform (Graphic: Business Wire)
The consumerization of IT has set high expectations among the increasingly mobile workforce. Users now expect immediate access to information, applications and the processes that drive the business regardless of where they are working or what device they are using. IT organizations are looking to work effectively with the business users to seamlessly and securely deliver process-centric content and applications, accessible anytime and anywhere. This business need for real-time data and information marks the beginning of a broader wave of digital transformation underway in enterprises around the globe. Organizations are continually seeking new ways to increase worker productivity and enable business process execution. However, doing so quickly and in line with corporate policies is a major challenge for IT organizations and business leaders alike.
ASG’s acquisition of Mowbly empowers enterprises to embrace this next era of digital transformation. The introduction of BPM capabilities allows users to easily define, manage and automate complex bi-directional processes, which are optimized for ASG solutions and can integrate with third-party systems and span multiple repositories. Users will also benefit from workflow services, giving them the ability to quickly define and execute workflows tied to policies such as document review and approval in ASG Mobius as well as responding to changes to critical data elements in ASG Enterprise Data Intelligence .
The integration with Mowbly also supports agile application development, wherein customers and partners can rapidly build web and mobile applications (including ASG Workspaces widgets) utilizing a low-code approach and visual designer that does not require specialized skills. With the ability to build workflows, processes and applications that leverage the existing content, analytic and delivery capabilities of the current ASG product suites on an open platform, businesses will be able to efficiently and securely connect users with the information and processes they need across PCs, tablets, smartphones and other mobile devices.
“Businesses are under intense pressure to extract actionable insights from their data, automate workflows and processes, and effectively govern the use of information and applications,” said Charles Sansbury, president and chief executive officer of ASG Technologies. “Mowbly’s approach to process mobility demonstrates a unique perspective and capability in the market today, one that addresses the needs of modern businesses to deliver great user experiences while flawlessly managing business processes. For ASG customers and partners, the addition of Mowbly’s process mobility capabilities ensures these two critical elements will always be aligned.”
“Enterprises often spend too much time thinking about solving a business problem in their approach to building a mobile app, instead of the actual need of enabling the business process that is at the core of the initiative,” said Vignesh Swaminathan, chief executive officer of Mowbly. “This principle was a driving force in how we developed our process mobility platform and a vision shared by ASG, which makes it the ideal company to take our capabilities to the next level.”
Today’s news continues the significant momentum ASG Technologies is demonstrating, recently marking nine consecutive quarters of year-over-year license revenue growth amid growing demand for its information management and systems solutions. To learn more about the company, its products and how it is helping enterprises add value to their businesses and succeed as the volume of business data continues to grow, visit www.asg.com .
About ASG Technologies
ASG Technologies brings peace of mind to every enterprise with information access, management and control for our customers. These solutions empower businesses to enhance workforce productivity, gain an accurate and timely understanding of the information that underpins business decisions and address compliance needs with improved visibility of cross-platform data from legacy to leading edge environments. Global Fortune 500 companies trust ASG Technologies to optimize their IT investments. ASG Technologies is a global provider of technology solutions with more than 1,000 people supporting over 3,000 global customers. For more information, visit http://www.asg.com .
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180307005343/en/
Contact information
ASG
Jessica Hohn-Cabana, 508-353-3454
Jessica.Hohn-Cabana@asg.com
or
Version
2.0 Communications
Kristen Leathers, 617-426-2222
ASG@v2comms.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
